Real-World Data & Market Intelligence software & AI news

Showing 58 results

Nov 4, 2026

POMDOCTOR LIMITED Advances Strategic Evolution from Traffic Monetization to Value-Based Healthcare Payment

Building a Four-Tier Revenue Structure Across B2C Services, AI-Enabled Chronic Disease Management, B2B Healthcare Services, and Pharmaceutical RWS/RWDGUANGZHOU, China, Nov. 4, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions, today provided an overview of its strategic evolution and business model transformation amid the rapid development of China's digital healthcare industry. S

Nov 4, 2026

TXP Medical Publishes Whitepaper "The State of Japanese Real-World Evidence," Analyzing the Current State of Real-World Evidence (RWE) in Japan

～ EMR-derived data market to grow from approx. ¥3.9 billion (2025) to approx. ¥25 billion (2035) ～～ RWD/RWE use in new approvals up from 18.1% (2019) to 30.4% (2024) ～～ Claims/DPC and EMR data: complementary roles clarified for Medical Affairs ～TOKYO, Nov. 3, 2026 /PRNewswire/ -- TXP Medical Co., Ltd. (Representative Director and CEO: Tomohiro Sonoo; "TXP Medical") has published the Whitepaper "The State of Japanese Real-World Evidence," a comprehensive analysis of how real-world data (RWD) and

Oct 29, 2026

Introducing FAIR Health Atlas

FAIR Health Launches Free Epidemiological Reporting Platform That Visualizes Data on 45 Chronic DiseasesNEW YORK, Oct. 29, 2026 /PRNewswire/ -- Today, FAIR Health launches FAIR Health Atlas, a free epidemiological reporting platform incorporating data on the commercially insured population. Atlas is an online tool that can provide insights to policy makers, researchers and others wishing to understand chronic disease prevalence trends and geographic variation over time. Drawing on FAIR Health's

Oct 29, 2026

Insira Launches as Independent Company Built on Cortellis and DRG

Company builds on industry-leading life sciences data and expertise to support the success of treatment innovation.NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Insira SM, formerly Clarivate Life Sciences & Healthcare, today introduced its new name and brand identity as a fully independent company serving the global life sciences and healthcare industry. With trusted, proprietary data assets and leading intelligence platforms, including Cortellis and DRG, Insira enters this next chapter to give li

Oct 27, 2026

Consumer Edge Launches Research Signal Healthcare to Help Investors Forecast Earnings

New Analyst-Built Reports Pair Revenue Forecasts with Insights Derived from Hospital Purchase, Medical Claims and Pharmacy Claims DataEach Quarter Provides an Intraquarter Trends Read and a Quarter-End Earnings Preview, with Estimates Positioned Against Consensus and Backtested Against Reported ResultsNEW YORK, Oct. 27, 2026 /PRNewswire/ -- Consumer Edge, the leading provider of global consumer data-driven insights, launched Research Signal Healthcare, the healthcare arm of Consumer Edge's Resea

Oct 26, 2026

ProclaimRx Launches The Next Generation Marketing Mix Modeling (MMM) Product for Commercial-Stage Biopharma Companies

Pharma-trained AI turns your MMM into a living operating model, giving commercial teams transparent, on-demand answers on how to maximize their investments.TIBURON, Calif., Oct. 26, 2026 /PRNewswire/ -- ProclaimRx, the award-winning pharma commercial intelligence and decision workflows platform, today launched its advanced MMM product.The MMM process has traditionally been a laborious, annual exercise. While valuable, these modeling efforts can take months to build. Often by the time the analysi

Oct 26, 2026

Florida Cancer Specialists & Research Institute Contributes To Real-World Analysis Demonstrating Ambient AI's Potential To Enhance Cancer Care And Reduce Administrative Burden for Providers

FORT MYERS, Fla., Oct. 26, 2026 /PRNewswire/ -- A study coauthored by Florida Cancer Specialists & Research Institute, LLC (FCS) President & Managing Physician Lucio N. Gordan, MD is among the first to assess and identify measurable improvements in documentation efficiency, timely chart completion and provider experience across community oncology practices with the use of ambient artificial intelligence (AI) scribe technology. A poster presentation of the study received first place honor

Oct 26, 2026

Tempus Expands Strategic Collaboration with Bristol Myers Squibb

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM, “Tempus”) today announced a multi-year agreement with Bristol Myers Squibb (NYSE: BMY, “BMS”), under which BMS will license multimodal oncology data from Tempus through 2031 to support biological and clinical insight identification, novel drug target discovery and therapeutic development across its oncology portfolio. With this agreement, BMS significantly expands its strategic relationship with Tempus and becomes one of Tempus’s largest li

Oct 23, 2026

BioVid Launches Mimetics™, AI Research Audiences Built on How Physicians Reason and Decide

Modeling physician response patterns and behavior, showing an 80–90% match with real physicians on content, reasoning, and emotion. BRISTOL, Pa., Oct. 23, 2026 /PRNewswire/ -- BioVid, a life science consultancy, today announced the launch of BioVid Mimetics™, a research platform that gives pharmaceutical teams mimetics: synthetic physician audiences modeled on how those audiences reason and decide. Its respondent models are grounded in BioVid's proprietary MindSet Modeling™ program, large-scale,

Oct 22, 2026

BioStack Raises $9.5M to Turn Global Hospital Data into Multimodal Training Datasets for Medical AI

Y Combinator startup transforms 100 million fragmented patient records into multimodal training data and reinforcement learning environments for medical AI agents.SAN FRANCISCO, Oct. 22, 2026 /PRNewswire/ -- BioStack, a healthcare technology company, announced today that it's launching a data infrastructure network to power the next era of medicine. It spans a global footprint across the U.S., India, Brazil, and Argentina with over 100 million de-identified patient records. By connecting fragmen

Oct 21, 2026

Walgreens Launches 2026-2027 Flu Index as Activity Tracks Four Weeks Ahead of Recent Seasons

New data highlights emerging respiratory illness trends and the importance of vaccination before activity increases locallyDEERFIELD, Ill., Oct. 21, 2026 /PRNewswire/ -- Walgreens today launched the 2026-2027 Walgreens Flu Index, an interactive online tool that tracks flu, COVID-19 and other acute respiratory illness activity nationwide. Updated weekly on Mondays, the Flu Index provides state- and county-level insights using multiple sources, including Walgreens flu and COVID-19 testing data, p

Oct 20, 2026

Flatiron Health Announces Research at ESMO Congress 2026 Examining Cancer Treatment and Outcomes Across Global Markets

Seventeen abstracts feature Flatiron data, including four studies exploring international treatment patterns, real-world treatment effectiveness, and opportunities to address gaps in colorectal, lung, and prostate cancer careNEW YORK--(BUSINESS WIRE)--Flatiron Health today announced that four research abstracts will be presented as e-posters at the European Society for Medical Oncology (ESMO) Congress 2026, taking place October 23–27 in Madrid, Spain. The research examines how cancer treatments

Page 1 of 5
Next

Real-World Data & Market Intelligence - software & AI news

Daily news on software, AI, and companies shaping real-world data & market intelligence.

Platform

Domains

Services

Legal